✦ LIBER ✦

Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]

✍ Scribed by Paul D Carey; Bavanisha Vythilingum; Soraya Seedat; Jacqueline E Muller; Michael van Ameringen; Dan J Stein

Book ID: 115012390
Publisher: BioMed Central
Year: 2005
Tongue: English
Weight: 224 KB
Volume: 5
Category: Article
ISSN: 1471-244X
DOI: 10.1186/1471-244x-5-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quetiapine augmentation of SRIs in treat

Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]

✍ Paul D Carey; Bavanisha Vythilingum; Soraya Seedat; Jacqueline E Muller; Michael 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 189 KB

Low-dose risperidone augmentation of flu

Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study

✍ Stefano Erzegovesi; Emanuela Guglielmo; Francesca Siliprandi; Laura Bellodi 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 126 KB

A double-blind, placebo-controlled trial

A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder

✍ Nathan A Shapira; Herbert E Ward; Miguel Mandoki; Tanya K Murphy; Mark C.K Yang; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Paroxetine in the treatment of obsessive

Paroxetine in the treatment of obsessive-compulsive disorder: randomized, double-blind, placebo-controlled study in Japanese patients

✍ KUNITOSHI KAMIJIMA; MITSUKUNI MURASAKI; MASAHIRO ASAI; TERUHIKO HIGUCHI; TERUO N 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

P-6-10 A placebo controlled double blind

P-6-10 A placebo controlled double blind study in obsessive compulsive disorder with fluvoxamine

✍ Y. Kudo 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 272 KB

A double-blind, placebo-controlled pilot

A double-blind, placebo-controlled pilot study of ondansetron for patients with obsessive-compulsive disorder

✍ Farhad Soltani; Mehdi Sayyah; Fariba Feizy; Alireza Malayeri; Amir Siahpoosh; Is 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 1 views

## Abstract ## Objective To assess the efficacy and tolerability of ondansetron in combination with selective serotonin reuptake inhibitors (SSRIs) in patients with obsessive‐compulsive disorder (OCD). ## Methods The study was an 8‐week pilot double‐blind randomized clinical trial. Forty‐two adu